Related Articles
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder
Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high‑risk region
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer
Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study